Clinical Trial Update: Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating losartan for efficacy and safety in pediatric chronic kidney disease with tubular proteinuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Proteinuria | Phase 3 | Status: COMPLETED